SCHEMBL4191135

SCHEMBL4191135

C[C@@H](CCc1ccccc1)NC1CCCc2c1[nH]c1ccccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RB1 P06400 8/20 0.54
▸ CYP2D6 P10635 2/20 0.52
▸ KCNH2 Q12809 1/20 0.52
▸ BRD3 Q15059 1/20 0.47
▸ CDC42 P60953 1/20 0.43
▸ GRIN2B Q13224 1/20 0.43
▸ SIRT2 Q8IXJ6 1/20 0.43
▸ SIRT1 Q96EB6 1/20 0.43
▸ ESR1 P03372 1/20 0.42
▸ ESR2 Q92731 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ TAAR1 Q96RJ0 1/20 0.41
▸ GAA P10253 1/20 0.40
▸ CASP6 P55212 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4148087 0.99 RB1 (0.55) RB1CYP2D6KCNH2BRD3CDC42
SCHEMBL15278247 0.84 RB1 (0.56) RB1CYP2D6KCNH2BRD3CDC42
SCHEMBL4192405 0.80 RB1 (0.60) RB1CYP2D6BRD3CDC42GRIN2B
SCHEMBL25287616 0.80 CYP2D6 (0.76) RB1CYP2D6KCNH2BRD3CDC42
SCHEMBL30455215 0.80 CYP2D6 (0.76) RB1CYP2D6KCNH2BRD3CDC42
SCHEMBL25247033 0.80 CYP2D6 (0.76) RB1CYP2D6KCNH2BRD3CDC42
SCHEMBL4196180 0.80 CYP2D6 (0.76) RB1CYP2D6KCNH2BRD3CDC42
SCHEMBL25248626 0.80 RB1 (0.62) RB1CYP2D6KCNH2BRD3CDC42
SCHEMBL25293118 0.80 RB1 (0.62) RB1CYP2D6KCNH2BRD3CDC42
Hydrochloric Acid SCHEMBL4157308 0.79 RB1 (0.60) RB1CYP2D6BRD3CDC42GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1658068-B1 NOVEL CYCLOALKYL[B] CONDENSED INDOLES SMITHKLINE BEECHAM CORP (US) 2009-02-18 — — EP claimed
US-7622494-B2 Chemical compounds SMITHKLINE BEECHAM CORPORATION (US) 2009-11-24 — — US disclosed
US-7622494-B2 Chemical compounds SMITHKLINE BEECHAM CORPORATION (US) 2009-11-24 — — US disclosed
US-20090170923-A1 HCV INHIBITORS SMITHKLINE BEECHAM CORPORATION 2009-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170923-A1 HCV INHIBITORS HAVCR2, MAVS, EIF2AK2 RB1 4460/4885CYP2D6 994/4885KCNH2 4356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback